Skip to content
Vol. IV · Issue III · 08 May 2026 N 40°42′47″ · W 74°00′21″ Cal. 2026-05-07 14:32 UTC · σ 0.61 ● Lab in session
PLATE I OxyRevo · Hyperbaric Oxygen Chambers N 40°42′ · W 74°00′ SCALE 1 : 1 device · N · NEARCTIC
Plate I · Hyperbaric Oxygen Chambers

OxyRevo

Widest pressure range of any single brand in the home/semi-clinical market — from entry-level 1.5 ATA soft-shell portables to full 2.0 ATA stainless steel hard-shell. Strong engineering credentials with 60+ patents.

· Not yet tested
BY · Biohacker Atlas Editorial Team · Editorial collective
PUB ·
NOT CLEARED

No FDA clearance, registration, or CE marking found.

No subscription
Visit OxyRevo → From $2,500
Fig. I · Bench readout

Key facts at a glance.

Founded
2012
Headquarters
Hangzhou, Zhejiang Province, China
Price range
$2,500–$5,500
Pricing as published by the manufacturer Trustpilot · refreshed weekly Bench measurements forthcoming
Fig. II · Cost of ownership

The real price over three years.

OxyRevo · 3-year horizon

Total cost of ownership · 3yr

Hardwareone-time$2,500
3-year total$2,500
Hardware · subscription · consumables · energy Year toggle: 1 / 2 / 3 / 5 Per § 3 of the legend
Fig. III · Key features

What the device does.

  • + Widest pressure range: 1.5 ATA soft-shell to 2.0 ATA hard-shell
  • + 60+ design patents
  • + Medical-grade TPU soft chambers, 4mm stainless steel hard chambers
  • + Heat-welded construction (not glued)
  • + Wheelchair-accessible Heal40 model
  • + Space60 premium recliner hard-shell design
  • + CE, Israeli Standard, ISO 9001, ISO 13485, TUV certified
  • + 3,000+ clients in 87+ countries
Fig. IV · Strengths & weaknesses

The trade-offs.

↑ Pros
  • + **Widest pressure range of any single brand** — entry 1.5 ATA soft-shell portables to full 2.0 ATA stainless hard-shell
  • + 60+ patents — strong engineering credentials within Chinese-manufacturer tier
  • + 2012-founded with established Hangzhou manufacturing infrastructure
  • + $2,500-5,500 pricing meaningfully cheaper than US-domestic alternatives
↓ Cons
  • **Not FDA-cleared for US market** (China-direct manufacturer)
  • Limited US support / warranty service
  • Brand awareness lower than US-domestic alternatives
  • Quality variance documented in Chinese-direct hyperbaric tier
  • Shipping logistics + customs friction
Fig. V · Best for

Serious home users, medspas, biohacking centers, athletes, clinical facilities

Fig. VI · Editorial review

The long read.

§ Hands-on instrument testing pending. Based on published specifications and third-party data.

Overview

OxyRevo is the widest-pressure-range Chinese-direct hyperbaric chamber specialist — founded 2012 in Hangzhou, with structural positioning combining single-brand pressure range from 1.5 ATA soft-shell portables to 2.0 ATA stainless steel hard-shell + 60+ patents engineering credentials at $2,500-5,500 pricing. The structural value claim is comprehensive single-brand catalog access at China-direct pricing vs piecing together from multiple manufacturers.

The structural editorial caveats parallel Macy-Pan: not FDA-cleared for US market (China-direct), limited US support / warranty, lower brand awareness, quality variance documented in Chinese-direct hyperbaric tier, and shipping / customs friction. For cost-priority international buyers wanting widest-pressure-range from single brand, OxyRevo is structurally appropriate. For US-FDA-cleared positioning, alternatives are structurally better.

When OxyRevo Makes Sense

Strong fit: Cost-priority international buyers wanting widest pressure range from single brand; 60+ patents engineering credentials priority within Chinese-direct tier; 2.0 ATA hard-shell at China-direct pricing.

Weaker fit: US-FDA-cleared positioning preference (Newtowne K051759, Summit to Sea K072757); US support priority; soft-shell residential 1.3 ATA at FDA-cleared tier (Newtowne is $1,995 cheaper).

3-Year Cost of Ownership

Use caseCost
OxyRevo soft-shell entry~$2,500-3,500
OxyRevo hard-shell 2.0 ATA~$4,500-5,500

Compare: Macy-Pan ($2,500-5,000 China direct), Newtowne ($4,495 FDA-cleared soft-shell), OxyHelp ($10K-20K European hard-shell), Henshaw ($4K-25K UK hard-shell).

Verdict: Conditional

OxyRevo earns a conditional verdict on the strength of its widest pressure range from single brand (1.5 ATA soft-shell to 2.0 ATA stainless hard-shell), 60+ patents engineering credentials, $2,500-5,500 China-direct pricing, and 2012-founded established manufacturing — balanced against not-FDA-cleared for US market, limited US support, lower brand awareness, quality variance in Chinese-direct tier, and shipping / customs friction.

For cost-priority international buyers wanting widest-pressure-range single-brand access, OxyRevo is structurally appropriate. For US-FDA-cleared positioning or US support priority, alternatives are structurally better matched.

Changelog

  • 2026-05-07: Initial review published based on OxyRevo published specifications, widest-pressure-range positioning, 60+ patents documentation, and aggregated user-report data.
Fig. VII · Hands-on protocol on file

What we'll measure on the bench.

Protocol
Pressure gauge + dB-A meter + stopwatch
Primary metric
Max ATA pressure + pressurization time
Pass threshold
±0.05 ATA of vendor claim · <70 dB-A
Session shape
3 pressurization cycles + ambient dB at 6 ft

§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.

← Back to Hyperbaric Oxygen Chambers territory